Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14751 | 752 | 41.7 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
144 | 3 | ENDOCRINOLOGY & METABOLISM//PITUITARY ADENOMA//GROWTH HORMONE | 64198 |
92 | 2 | GROWTH HORMONE//GROWTH HORMONE & IGF RESEARCH//ENDOCRINOLOGY & METABOLISM | 26472 |
14751 | 1 | INSULIN LIKE GROWTH FACTOR 1//MED 0613B//INTERNAL MED CARDIOVASC SCI | 752 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INSULIN LIKE GROWTH FACTOR 1 | authKW | 119010 | 9% | 5% | 65 |
2 | MED 0613B | address | 91358 | 0% | 75% | 3 |
3 | INTERNAL MED CARDIOVASC SCI | address | 86537 | 1% | 24% | 9 |
4 | GROWTH HORMONE & IGF RESEARCH | journal | 67251 | 6% | 4% | 43 |
5 | TULANE UNIV HEART VASC | address | 54138 | 0% | 67% | 2 |
6 | IGF 1 | authKW | 50405 | 7% | 2% | 50 |
7 | INSULIN LIKE GROWTH FACTOR I | authKW | 46108 | 7% | 2% | 52 |
8 | 0613C | address | 40604 | 0% | 100% | 1 |
9 | ACETYL COA ACYLTRANSFERASE ACAA1B | authKW | 40604 | 0% | 100% | 1 |
10 | ACUTE HEALTHCARE | address | 40604 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 4366 | 30% | 0% | 224 |
2 | Cardiac & Cardiovascular System | 3914 | 29% | 0% | 217 |
3 | Peripheral Vascular Diseases | 2933 | 19% | 0% | 141 |
4 | Cell Biology | 494 | 15% | 0% | 111 |
5 | Geriatrics & Gerontology | 184 | 3% | 0% | 22 |
6 | Physiology | 151 | 6% | 0% | 44 |
7 | Hematology | 138 | 5% | 0% | 37 |
8 | Medicine, Research & Experimental | 99 | 5% | 0% | 41 |
9 | Gerontology | 92 | 2% | 0% | 12 |
10 | Medicine, General & Internal | 21 | 4% | 0% | 32 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MED 0613B | 91358 | 0% | 75% | 3 |
2 | INTERNAL MED CARDIOVASC SCI | 86537 | 1% | 24% | 9 |
3 | TULANE UNIV HEART VASC | 54138 | 0% | 67% | 2 |
4 | 0613C | 40604 | 0% | 100% | 1 |
5 | ACUTE HEALTHCARE | 40604 | 0% | 100% | 1 |
6 | ADV STUDIES TRANSLAT AGING UNITNIH | 40604 | 0% | 100% | 1 |
7 | AIMMC | 40604 | 0% | 100% | 1 |
8 | ALCOHOL UNITHOSP CLIN MED | 40604 | 0% | 100% | 1 |
9 | ANAT PATHOL 8700 BEVERLY BLVD | 40604 | 0% | 100% | 1 |
10 | ANTIBLAST DRUG UNIT | 40604 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GROWTH HORMONE & IGF RESEARCH | 67251 | 6% | 4% | 43 |
2 | ENDOCRINOLOGY AND METABOLISM | 4620 | 0% | 4% | 3 |
3 | EUROPEAN JOURNAL OF ENDOCRINOLOGY | 4124 | 3% | 0% | 23 |
4 | CIRCULATION RESEARCH | 2482 | 3% | 0% | 25 |
5 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1501 | 4% | 0% | 30 |
6 | CARDIOVASCULAR RESEARCH | 1476 | 2% | 0% | 17 |
7 | ENDOCRINOLOGY | 1071 | 3% | 0% | 26 |
8 | AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 919 | 2% | 0% | 17 |
9 | HYPERTENSION | 880 | 2% | 0% | 16 |
10 | JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES | 879 | 1% | 0% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ISGAARD, J , ARCOPINTO, M , KARASON, K , CITTADINI, A , (2015) GH AND THE CARDIOVASCULAR SYSTEM: AN UPDATE ON A TOPIC AT HEART.ENDOCRINE. VOL. 48. ISSUE 1. P. 25 -35 | 68 | 52% | 12 |
2 | ARCOPINTO, M , BOBBIO, E , BOSSONE, E , PERRONE-FILARDI, P , NAPOLI, R , SACCA, L , CITTADINI, A , (2013) THE GH/IGF-1 AXIS IN CHRONIC HEART FAILURE.ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS. VOL. 13. ISSUE 1. P. 76-91 | 60 | 53% | 7 |
3 | TIVESTEN, A , ISGAARD, J , (2005) CARDIOVASCULAR AND RESPIRATORY SYSTEMS.GROWTH HORMONE/INSULIN-LIKE GROWTH FACTOR AXIS DURING DEVELOPMENT. VOL. 567. ISSUE . P. 149 -166 | 63 | 61% | 0 |
4 | CONTI, E , MUSUMECI, MB , DE GIUSTI, M , DITO, E , MASTROMARINO, V , AUTORE, C , VOLPE, M , (2011) IGF-1 AND ATHEROTHROMBOSIS: RELEVANCE TO PATHOPHYSIOLOGY AND THERAPY.CLINICAL SCIENCE. VOL. 120. ISSUE 9-10. P. 377 -402 | 88 | 30% | 29 |
5 | SCHUTTE, AE , CONTI, E , MELS, CMC , SMITH, W , KRUGER, R , BOTHA, S , GNESSI, L , VOLPE, M , HUISMAN, HW , (2016) ATTENUATED IGF-1 PREDICTS ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN A BLACK POPULATION: A FIVE-YEAR PROSPECTIVE STUDY.EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. VOL. 23. ISSUE 16. P. 1690 -1699 | 39 | 55% | 0 |
6 | SCHUTTE, AE , VOLPE, M , TOCCI, G , CONTI, E , (2014) REVISITING THE RELATIONSHIP BETWEEN BLOOD PRESSURE AND INSULIN- LIKE GROWTH FACTOR-1.HYPERTENSION. VOL. 63. ISSUE 5. P. 1070-1077 | 38 | 52% | 9 |
7 | HIGASHI, Y , SUKHANOV, S , ANWAR, A , SHAI, SY , DELAFONTAINE, P , (2012) AGING, ATHEROSCLEROSIS, AND IGF-1.JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. VOL. 67. ISSUE 6. P. 626 -639 | 58 | 30% | 61 |
8 | AGARWAL, M , SCHWARZ, ER , WILLIX, RD , PHAN, A , PHILIP, K , NAGHI, J , (2010) GROWTH HORMONE AND TESTOSTERONE IN HEART FAILURE THERAPY.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 11. ISSUE 11. P. 1835-1844 | 43 | 52% | 4 |
9 | DEMERS, C , MCKELVIE, RS , (2005) GROWTH HORMONE THERAPY IN HEART FAILURE: A NOVEL THERAPY WORTHY OF FURTHER CONSIDERATION.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 14. ISSUE 8. P. 1009-1018 | 40 | 63% | 1 |
10 | HIGASHI, Y , SUKHANOV, S , SHAI, SY , DANCHUK, S , TANG, R , SNARSKI, P , LI, ZH , LOBELLE-RICH, P , WANG, MF , WANG, D , ET AL (2016) INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR DEFICIENCY IN MACROPHAGES ACCELERATES ATHEROSCLEROSIS AND INDUCES AN UNSTABLE PLAQUE PHENOTYPE IN APOLIPOPROTEIN E-DEFICIENT MICE.CIRCULATION. VOL. 133. ISSUE 23. P. 2263 -+ | 38 | 41% | 1 |
Classes with closest relation at Level 1 |